Motilal Oswal Flags 9–11% Pharma Growth in India by FY 26; Recommends Five Stocks

Motilal Oswal Wealth Management projects India’s pharmaceutical sector to grow at 9–11% by fiscal 2026 and has spotlighted five pharma and healthcare stocks—Lupin, Mankind Pharma, Piramal Pharma, IPCA Labs, and…

We want assurance of quality of generic medicines, says IMA President

NEW DELHI : Indian Medical Association (IMA) president Dr Sharad Agarwal has raised concerns over the quality of generic medicine made in India. In an interview, he also raised concerns…